2-(Methylsulfanyl)-5-{4H,5H-naphtho[1,2-b]thiophen-2-yl}-1,3,4-oxadiazole

Catalog No.: 
ACAKZB731
CAS No.: 
477888-00-9
Molecular Formula: 
C15H12N2OS2
Molecular Weight: 
300.41
2-(Methylsulfanyl)-5-{4H,5H-naphtho[1,2-b]thiophen-2-yl}-1,3,4-oxadiazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%
1g90%
5g90%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Methylsulfanyl)-5-{4H,5H-naphtho[1,2-b]thiophen-2-yl}-1,3,4-oxadiazole
IUPAC Name2-(4,5-dihydronaphtho[1,2-b]thiophen-2-yl)-5-(methylthio)-1,3,4-oxadiazole
Molecular FormulaC15H12N2OS2
Molecular Weight300.41
SMILESCSC1=NN=C(C2=CC(CCC3=C4C=CC=C3)=C4S2)O1
InChI KeyYTESSBCNMNDZIN-UHFFFAOYSA-N
Synonym2-(methylsulfanyl)-5-{4H,5H-naphtho[1,2-b]thiophen-2-yl}-1,3,4-oxadiazole;2-(4,5-DIHYDRONAPHTHO[1,2-B]THIOPHEN-2-YL)-5-(METHYLSULFANYL)-1,3,4-OXADIAZOLE;5-(4,5-DIHYDRONAPHTHO[1,2-B]THIOPHEN-2-YL)-1,3,4-OXADIAZOL-2-YL METHYL SULFIDE;1,3,4-Oxadiazole, 2-(4,5-dihydronaphtho[1,2-b]thien-2-yl)-5-(methylthio)-
CAS No.477888-00-9

Synthetic Route by SureRoute

1. ACAKZB731 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAKZB731 route product structure diagram
    ACAKZB731477888-00-9
Inquiry

2. ACAKZB731 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAKZB731 route product structure diagram
    ACAKZB731477888-00-9
Inquiry

3. ACAKZB731 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAKZB731 route product structure diagram
    ACAKZB731477888-00-9
Inquiry

Comments (0)